Study to Assess the Bioavailability, Pharmacokinetics, Safety, and Tolerability of AVP-923 in Healthy Adult Participants
Clinical trial NCT03381664 · COMPLETED
Trial details
- NCT number
- NCT03381664
- Sponsor
- Avanir Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-28
- Primary completion
- 2018-01-30
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.